Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PureTech Scientific is a leading global manufacturer of high-purity glycolic acid, primarily serving the life sciences, personal care, and specialty industrial markets. The company was established in 2023 following the acquisition of the Glycolic Acid business from The Chemours Company by the private equity firm Iron Path Capital. Operating the world's largest dedicated glycolic acid production facility in Belle, West Virginia, the company provides essential chemical building blocks for pharmaceutical synthesis and medical devices, including absorbable sutures. PureTech Scientific is positioned as a critical supplier for regulated industries, emphasizing technical expertise and high-quality manufacturing standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PureTech Scientific.